India - based medical technology company ReviveMed has raised $ 1.5 m to use artificial intelligence ( AI ) to discover connections between existing drugs and diseases with no known solution . The research will focus on the study of proteins and metabolites , biomolecules that have greater variety than proteins . Past experiments have led to only a partial understanding of a small number of known metabolites . What wouldn’t Pfizer pay to determine that Robitussin also prevents Alzheimer ReviveMed founder and CEO Leila Pirhaji said the costs of separate testing have made metabolites difficult to study so the company decided to use to Google to analyse its database . The initial funding round was led by Rivas Capital .
India - based medical technology company ReviveMed has raised $ 1.5 m to use artificial intelligence ( AI ) to discover connections between existing drugs and diseases with no known solution . The research will focus on the study of proteins and metabolites , biomolecules that have greater variety than proteins . Past experiments have led to only a partial understanding of a small number of known metabolites . ReviveMed founder and CEO Leila Pirhaji said the costs of separate testing have made metabolites difficult to study so the company decided to use to Google to analyse its database . The initial funding round was led by Rivas Capital .